| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8436930 | EBioMedicine | 2018 | 11 Pages |
Abstract
Salivary lnc-PCDH9-13:1 is a desirable biomarker for early HCC. It may help warrant prospective validation with larger sample sizes in multi-centers.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Zijun Xie, Fangyuan Zhou, Yidong Yang, Leijia Li, Yiming Lei, Xianyi Lin, Haijiao Li, Xuemei Pan, Jianning Chen, Genshu Wang, Huiling Liu, Jie Jiang, Bin Wu,